The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice paper
Affiliation
Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UKIssue Date
2019
Metadata
Show full item recordCitation
Cwynarski K, Marzolini MAV, Barrington SF, Follows G, Illidge T, Stern S, et al. The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice Paper. Br J Haematol. 2019.Journal
British Journal of HaematologyDOI
10.1111/bjh.15731PubMed ID
30609016Additional Links
https://dx.doi.org/10.1111/bjh.15731Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1111/bjh.15731
Scopus Count
Collections
Related articles
- [Primary mediastinal B-cell lymphoma].
- Authors: Coso D, Rey J, Bouabdallah R
- Issue date: 2010 Feb
- The management of primary mediastinal B-cell lymphoma with sclerosis.
- Authors: Brugger W, Engelhardt R, Mertelsmann R, Kanz L
- Issue date: 1994 Dec
- Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma.
- Authors: Kuruvilla J, Pintilie M, Tsang R, Nagy T, Keating A, Crump M
- Issue date: 2008 Jul
- Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic stem cell transplantation.
- Authors: Nath SV, Seymour JF
- Issue date: 2005 Jul
- Favorable response of relapsed/refractory gray-zone lymphoma to brentuximab vedotin.
- Authors: Li J, Sim J, Leung AYH, Kwong YL
- Issue date: 2018 Mar